| AURV01000001.1_1 |
95.556 |
5.71E-26 |
vgrG/tssI |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(vgrG/tssI) type VI secretion system effector VgrG [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000001.1_2 |
94.684 |
0.0 |
vgrG/tssI |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(vgrG/tssI) type VI secretion system effector VgrG [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000002.1_16 |
67.539 |
7.96E-100 |
sodB |
VF0169 |
SodB |
Stress survival |
VFC0282 |
|
(sodB) superoxide dismutase [SodB (VF0169) - Stress survival (VFC0282)] [Legionella pneumophila subsp. pneumophila str. Philadelphia 1] |
Legionella pneumophila |
| AURV01000011.1_2 |
85.072 |
0.0 |
flhA |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flhA) flagellar biosynthesis protein FlhA [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_3 |
65.172 |
2.72E-178 |
flhB |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flhB) flagellar biosynthetic protein FlhB [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_4 |
77.67 |
1.61E-108 |
cheZ |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(cheZ) chemotaxis regulator CheZ [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_5 |
91.473 |
1.1E-84 |
cheY |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(cheY) chemotaxis regulatory protein CheY [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_6 |
85.96 |
0.0 |
cheB |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(cheB) chemotaxis-specific methylesterase CheB [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_7 |
72.101 |
1.36E-145 |
cheR |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(cheR) chemotaxis methyltransferase CheR [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_10 |
85.093 |
3.74E-98 |
cheW |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(cheW) purine-binding chemotaxis protein CheW [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_11 |
73.56 |
0.0 |
cheA |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(cheA) chemotaxis protein CheA [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_12 |
68.987 |
9.25E-153 |
motB |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(motB) flagellar motor protein MotB [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_13 |
80.678 |
6.68E-180 |
motA |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(motA) flagellar motor protein MotA [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_14 |
82.902 |
6.95E-117 |
flhC |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flhC) flagellar biosynthesis transcription activator FlhC [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_15 |
72.414 |
5.04E-52 |
flhD |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flhD) flagellar transcriptional activator FlhD [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_39 |
83.613 |
5.39E-145 |
fliA |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliA) flagellar biosynthesis sigma factor [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_55 |
62.837 |
0.0 |
fliF |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliF) flagellar M-ring protein FliF [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_56 |
83.587 |
0.0 |
fliG |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliG) flagellar motor switch protein G [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_58 |
83.26 |
0.0 |
fliI |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliI) flagellum-specific ATP synthase FliI [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_62 |
84.384 |
0.0 |
fliM |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliM) flagellar motor switch protein FliM [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_63 |
74.638 |
3.17E-69 |
fliN |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliN) flagellar motor switch protein FliN [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_65 |
80.972 |
4.42E-141 |
fliP |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliP) flagellar biosynthetic protein FliP [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_66 |
77.528 |
1.94E-37 |
fliQ |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliQ) flagellar biosynthetic protein FliQ [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_67 |
68.605 |
1.61E-108 |
fliR |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(fliR) flagellar biosynthetic protein FliR [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000011.1_68 |
67.633 |
4.25E-102 |
rcsA |
VF0571 |
RcsAB |
Regulation |
VFC0301 |
|
(rcsA) transcriptional activator for ctr capsule biosynthesis [RcsAB (VF0571) - Regulation (VFC0301)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000016.1_16 |
75.568 |
0.0 |
htpB |
VF0159 |
Hsp60 |
Adherence |
VFC0001 |
|
(htpB) Hsp60, 60K heat shock protein HtpB [Hsp60 (VF0159) - Adherence (VFC0001)] [Legionella pneumophila subsp. pneumophila str. Philadelphia 1] |
Legionella pneumophila |
| AURV01000018.1_18 |
99.133 |
0.0 |
ompA |
VF0236 |
OmpA |
Invasion |
VFC0083 |
Major outer membrane protein in E. coli, homologous to Neisseria Opa proteins which have been shown to be involved in invasion of eukaryotic cells |
(ompA) outer membrane protein A [OmpA (VF0236) - Invasion (VFC0083)] [Escherichia coli O18:K1:H7 str. RS218] |
Escherichia coli (NMEC) |
| AURV01000019.1_13 |
99.133 |
0.0 |
ibeC |
VF0237 |
Ibes |
Invasion |
VFC0083 |
IbeA is unique to E. coli K1. The ibeB and ibeC are found to have K12 homologues p77211 and yijP respectively. |
(ibeC) phosphoethanolamine transferase CptA [Ibes (VF0237) - Invasion (VFC0083)] [Escherichia coli O45:K1:H7 str. S88] |
Escherichia coli (NMEC) |
| AURV01000028.1_51 |
96.759 |
1.41E-152 |
rcsB |
VF0571 |
RcsAB |
Regulation |
VFC0301 |
|
(rcsB) transcriptional regulator RcsB [RcsAB (VF0571) - Regulation (VFC0301)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000030.1_71 |
69.3 |
0.0 |
cheD |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(cheD) methyl-accepting chemotaxis protein CheD [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000035.1_5 |
100.0 |
2.61E-151 |
AAA92657 |
VF0241 |
TraJ |
Invasion |
VFC0083 |
Belongs to a cluster of genes within the F-like plasmid R1-19 transfer region called the tra operon; homology with a component of the bacterial conjugation system |
(AAA92657) unknown protein [TraJ (VF0241) - Invasion (VFC0083)] [Escherichia coli] |
Escherichia coli (NMEC) |
| AURV01000038.1_28 |
78.247 |
0.0 |
rfaD |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(rfaD) ADP-L-glycero-D-mannoheptose-6-epimerase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000038.1_29 |
63.218 |
4.84E-158 |
rfaF |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(rfaF) ADP-heptose-LPS heptosyltransferase II [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000040.1_4 |
67.897 |
3.63E-128 |
IlpA |
VF0513 |
IlpA |
Adherence |
VFC0001 |
|
(IlpA) immunogenic lipoprotein A [IlpA (VF0513) - Adherence (VFC0001)] [Vibrio vulnificus YJ016] |
Vibrio vulnificus |
| AURV01000040.1_20 |
63.542 |
1.28E-177 |
lpxB |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(lpxB) lipid-A-disaccharide synthase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000040.1_21 |
67.557 |
1.62E-132 |
lpxA |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(lpxA) UDP-N-acetylglucosamine acyltransferase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000040.1_23 |
65.385 |
8.0E-161 |
lpxD |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(lpxD) UDP-3-O-(3-hydroxymyristoyl) glucosamine N-acyltransferase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000041.1_18 |
94.702 |
5.52E-100 |
espL1 |
VF1110 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espL1) Type III secretion system effector espL1 [TTSS secreted effectors (VF1110) - Effector delivery system (VFC0086)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000041.1_19 |
97.388 |
0.0 |
espL1 |
VF1110 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espL1) Type III secretion system effector espL1 [TTSS secreted effectors (VF1110) - Effector delivery system (VFC0086)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000042.1_34 |
73.099 |
4.94E-96 |
luxS |
VF0406 |
AI-2 |
Biofilm |
VFC0271 |
AI-2 is produced and detected by a wide variety of bacteria and is presumed to facilitate interspecies communications. |
(luxS) S-ribosylhomocysteinase [AI-2 (VF0406) - Biofilm (VFC0271)] [Vibrio cholerae O1 biovar El Tor str. N16961] |
Vibrio cholerae |
| AURV01000042.1_39 |
76.667 |
1.4E-30 |
csrA |
VF0261 |
CsrA |
Regulation |
VFC0301 |
Belongs to a highly conserved family of global regulators that typically control stationary phase traits post-transcriptionally |
(csrA) carbon storage regulator CsrA [CsrA (VF0261) - Regulation (VFC0301)] [Legionella pneumophila subsp. pneumophila str. Philadelphia 1] |
Legionella pneumophila |
| AURV01000042.1_85 |
99.394 |
0.0 |
rpoS |
VF0112 |
RpoS |
Regulation |
VFC0301 |
|
(rpoS) RNA polymerase sigma factor RpoS [RpoS (VF0112) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000044.1_1 |
81.356 |
8.18E-29 |
tufA |
VF0460 |
EF-Tu |
Adherence |
VFC0001 |
|
(tufA) elongation factor Tu [EF-Tu (VF0460) - Adherence (VFC0001)] [Francisella tularensis subsp. tularensis SCHU S4] |
Francisella tularensis |
| AURV01000044.1_20 |
66.832 |
1.28E-99 |
vfr |
VF0082 |
Type IV pili |
Adherence |
VFC0001 |
PilA, B, C, D, E, F, M, N, O, P, Q, T, U, V, W, X, Y1, Y2, Z, and fimT, U, V are involved in the biogenesis and mechanical function of pili, pilG, H, I, K, chpA, B, C, D, E, pilS, R, fimS, rpoN, algR, algU, and vfr are involved in transcriptional regulation and chemosensory pathways that control the expression or activity of the twitching motility of the pili |
(vfr) cAMP-regulatory protein [Type IV pili (VF0082) - Adherence (VFC0001)] [Pseudomonas aeruginosa PAO1] |
Pseudomonas aeruginosa |
| AURV01000045.1_74 |
66.495 |
8.54E-98 |
clpP |
VF0074 |
ClpP |
Stress survival |
VFC0282 |
21.6 kDa protein belongs to a family of proteases highly conserved in prokaryotes and eukaryotes |
(clpP) ATP-dependent Clp protease proteolytic subunit [ClpP (VF0074) - Stress survival (VFC0282)] [Listeria monocytogenes EGD-e] |
Listeria monocytogenes |
| AURV01000048.1_20 |
77.303 |
0.0 |
lpxC |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(lpxC) UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000049.1_24 |
78.689 |
5.34E-26 |
espX4 |
VF1110 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espX4) Type III secretion system effector EspX4 [TTSS secreted effectors (VF1110) - Effector delivery system (VFC0086)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000049.1_25 |
88.662 |
0.0 |
espX4 |
VF1110 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espX4) Type III secretion system effector EspX4 [TTSS secreted effectors (VF1110) - Effector delivery system (VFC0086)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000050.1_1 |
66.498 |
0.0 |
etpB |
VF0437 |
EtpA |
Adherence |
VFC0001 |
|
(etpB) two-partner secretion transporter EtpB [EtpA (VF0437) - Adherence (VFC0001)] [Escherichia coli O78:H11:K80 str. H10407] |
Escherichia coli (ETEC) |
| AURV01000052.1_7 |
93.274 |
2.15E-157 |
phoP |
VF0111 |
PhoPQ |
Regulation |
VFC0301 |
|
(phoP) response regulator in two-component regulatory system with PhoQ [PhoPQ (VF0111) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000052.1_8 |
85.216 |
0.0 |
phoQ |
VF0111 |
PhoPQ |
Regulation |
VFC0301 |
|
(phoQ) sensor protein PhoQ [PhoPQ (VF0111) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000054.1_2 |
99.77 |
0.0 |
ybtS |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(ybtS) salicylate synthase Irp9 [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_3 |
99.296 |
0.0 |
ybtX |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(ybtX) putative signal transducer [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_4 |
99.667 |
0.0 |
ybtQ |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(ybtQ) yersiniabactin ABC transporter ATP-binding/permease protein YbtQ [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_5 |
99.649 |
0.0 |
ybtP |
VF0564 |
Ybt |
Nutritional/Metabolic factor |
VFC0272 |
Ybt is the most common virulence factor associated with human K. pneumoniae infections |
(ybtP) yersiniabactin ABC transporter ATP-binding/permease protein YbtP [Ybt (VF0564) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000054.1_6 |
99.687 |
0.0 |
ybtA |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(ybtA) transcriptional regulator YbtA [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_7 |
99.558 |
0.0 |
irp2 |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(irp2) yersiniabactin biosynthetic protein Irp2 [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_8 |
99.684 |
0.0 |
irp1 |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(irp1) yersiniabactin biosynthetic protein Irp1 [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_9 |
100.0 |
0.0 |
ybtU |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(ybtU) yersiniabactin biosynthetic protein YbtU [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_10 |
99.251 |
0.0 |
ybtT |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(ybtT) type II thioesterase YbtT [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_11 |
99.81 |
0.0 |
ybtE |
VF0136 |
Yersiniabactin |
Nutritional/Metabolic factor |
VFC0272 |
One of the major differences between low- and high-pathogenicity Yersinia lies in their ability to capture the iron molecules necessary for their systemic dissemination in the host |
(ybtE) yersiniabactin siderophore biosynthetic protein [Yersiniabactin (VF0136) - Nutritional/Metabolic factor (VFC0272)] [Yersinia pestis CO92] |
Yersinia pestis |
| AURV01000054.1_12 |
99.851 |
0.0 |
fyuA |
VF0564 |
Ybt |
Nutritional/Metabolic factor |
VFC0272 |
Ybt is the most common virulence factor associated with human K. pneumoniae infections |
(fyuA) yersiniabactin receptor FyuA [Ybt (VF0564) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000057.1_4 |
71.03 |
0.0 |
rfaE |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(rfaE) ADP-heptose synthase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000058.1_34 |
61.538 |
1.93E-27 |
acpXL |
VF0367 |
LPS |
Immune modulation |
VFC0258 |
Brucella possesses a non-classical LPS as compared with the so-called classical LPS from enterobacteria such as Escherichia coli. B. abortus lipid A possesses a diaminoglucose backbone (rather than glucosamine), and acyl groups are longer (C28 rather than C12 and C16) and are only linked to the core by amide bounds (rather than ester and amide bonds).; In contrast to enterobacterial LPSs, Brucella LPS is several-hundred-times less active and toxic than E. coli LPS.; this is an evolutionary adaptation to an intracellular lifestyle, low endotoxic activity is shared by other intracellular pathogens such as Bartonella and Legionella. |
(acpXL) acyl carrier protein [LPS (VF0367) - Immune modulation (VFC0258)] [Brucella melitensis bv. 1 str. 16M] |
Brucella melitensis |
| AURV01000058.1_35 |
77.459 |
7.98E-140 |
flmH |
VF0473 |
Polar flagella |
Motility |
VFC0204 |
Types of bacterial movement: swimming, swarming, gliding, twitching and sliding. Only swimming and swarming are correlated with the presence of flagella. Swimming is an individual endeavour, while swarming is the movement of a group of bacteria; constitutively expressed for motility in liquid environments |
(flmH) short chain dehydrogenase/reductase family oxidoreductase [Polar flagella (VF0473) - Motility (VFC0204)] [Aeromonas hydrophila ML09-119] |
Aeromonas hydrophila |
| AURV01000058.1_46 |
60.458 |
1.46E-129 |
flgJ |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgJ) <beta>-N-acetylglucosaminidase [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_47 |
78.356 |
0.0 |
flgI |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgI) flagellar P-ring protein precursor FlgI [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_48 |
81.193 |
3.69E-122 |
flgH |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgH) flagellar L-ring protein precursor FlgH [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_49 |
86.923 |
7.79E-170 |
flgG |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgG) flagellar basal-body rod protein FlgG [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_50 |
66.534 |
8.85E-121 |
flgF |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgF) flagellar basal-body rod protein FlgF [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_51 |
62.768 |
4.02E-179 |
flgE |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgE) flagellar hook protein FlgE [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_52 |
75.248 |
8.45E-105 |
flgD |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgD) flagellar basal-body rod modification protein FlgD [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_53 |
83.582 |
7.9E-82 |
flgC |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgC) flagellar basal-body rod protein FlgC [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_54 |
70.803 |
6.66E-73 |
flgB |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgB) flagellar basal-body rod protein FlgB [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_56 |
62.626 |
1.86E-34 |
flgM |
VF0394 |
Flagella |
Motility |
VFC0204 |
|
(flgM) negative regulator of flagellin synthesis [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] |
Yersinia enterocolitica |
| AURV01000058.1_83 |
98.182 |
2.39E-75 |
csgC |
VF1138 |
Curli fibers |
Adherence |
VFC0001 |
Many commensal E. coli strains and the commonly studied lab strains express curli at temperatures of <30°C. In contrast, pathogenic E. coli strains like UPECs, EAECs including the 2012 German outbreak strain and S. Typhimurium, have been shown to express curli at 37°C |
(csgC) curli assembly protein CsgC [Curli fibers (VF1138) - Adherence (VFC0001)] [Escherichia coli O25b:H4-ST131] |
Escherichia coli (UPEC) |
| AURV01000058.1_84 |
97.368 |
2.19E-101 |
csgA |
VF1138 |
Curli fibers |
Adherence |
VFC0001 |
Many commensal E. coli strains and the commonly studied lab strains express curli at temperatures of <30°C. In contrast, pathogenic E. coli strains like UPECs, EAECs including the 2012 German outbreak strain and S. Typhimurium, have been shown to express curli at 37°C |
(csgA) curlin major subunit CsgA [Curli fibers (VF1138) - Adherence (VFC0001)] [Escherichia coli O25b:H4-ST131] |
Escherichia coli (UPEC) |
| AURV01000058.1_85 |
100.0 |
1.13E-106 |
csgB |
VF1138 |
Curli fibers |
Adherence |
VFC0001 |
Many commensal E. coli strains and the commonly studied lab strains express curli at temperatures of <30°C. In contrast, pathogenic E. coli strains like UPECs, EAECs including the 2012 German outbreak strain and S. Typhimurium, have been shown to express curli at 37°C |
(csgB) curlin minor subunit CsgB [Curli fibers (VF1138) - Adherence (VFC0001)] [Escherichia coli O25b:H4-ST131] |
Escherichia coli (UPEC) |
| AURV01000058.1_86 |
99.074 |
3.13E-161 |
cgsD |
VF1138 |
Curli fibers |
Adherence |
VFC0001 |
Many commensal E. coli strains and the commonly studied lab strains express curli at temperatures of <30°C. In contrast, pathogenic E. coli strains like UPECs, EAECs including the 2012 German outbreak strain and S. Typhimurium, have been shown to express curli at 37°C |
(cgsD) transcriptional regulator CsgD [Curli fibers (VF1138) - Adherence (VFC0001)] [Escherichia coli O25b:H4-ST131] |
Escherichia coli (UPEC) |
| AURV01000058.1_87 |
99.225 |
4.66E-94 |
cgsE |
VF1138 |
Curli fibers |
Adherence |
VFC0001 |
Many commensal E. coli strains and the commonly studied lab strains express curli at temperatures of <30°C. In contrast, pathogenic E. coli strains like UPECs, EAECs including the 2012 German outbreak strain and S. Typhimurium, have been shown to express curli at 37°C |
(cgsE) curli production assembly/transport protein CsgE [Curli fibers (VF1138) - Adherence (VFC0001)] [Escherichia coli O25b:H4-ST131] |
Escherichia coli (UPEC) |
| AURV01000058.1_88 |
99.275 |
1.6E-99 |
cgsF |
VF1138 |
Curli fibers |
Adherence |
VFC0001 |
Many commensal E. coli strains and the commonly studied lab strains express curli at temperatures of <30°C. In contrast, pathogenic E. coli strains like UPECs, EAECs including the 2012 German outbreak strain and S. Typhimurium, have been shown to express curli at 37°C |
(cgsF) curli production assembly/transport protein CsgF [Curli fibers (VF1138) - Adherence (VFC0001)] [Escherichia coli O25b:H4-ST131] |
Escherichia coli (UPEC) |
| AURV01000058.1_89 |
99.639 |
0.0 |
cgsG |
VF1138 |
Curli fibers |
Adherence |
VFC0001 |
Many commensal E. coli strains and the commonly studied lab strains express curli at temperatures of <30°C. In contrast, pathogenic E. coli strains like UPECs, EAECs including the 2012 German outbreak strain and S. Typhimurium, have been shown to express curli at 37°C |
(cgsG) curli production assembly/transport protein CsgG [Curli fibers (VF1138) - Adherence (VFC0001)] [Escherichia coli O25b:H4-ST131] |
Escherichia coli (UPEC) |
| AURV01000060.1_28 |
74.479 |
8.28E-108 |
gmhA/lpcA |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(gmhA/lpcA) phosphoheptose isomerase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000060.1_34 |
88.137 |
0.0 |
rhs/PAAR |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(rhs/PAAR) Type VI secretion system protein, PAAR family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000060.1_35 |
99.524 |
4.73E-147 |
vgrG/tssI |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(vgrG/tssI) type VI secretion system effector VgrG [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000061.1_32 |
66.782 |
0.0 |
msbA |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(msbA) lipid transporter ATP-binding/permease [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000061.1_36 |
69.88 |
5.94E-127 |
nueA |
VF0473 |
Polar flagella |
Motility |
VFC0204 |
Types of bacterial movement: swimming, swarming, gliding, twitching and sliding. Only swimming and swarming are correlated with the presence of flagella. Swimming is an individual endeavour, while swarming is the movement of a group of bacteria; constitutively expressed for motility in liquid environments |
(nueA) NeuA protein [Polar flagella (VF0473) - Motility (VFC0204)] [Aeromonas hydrophila ML09-119] |
Aeromonas hydrophila |
| AURV01000065.1_15 |
96.112 |
0.0 |
aslA |
VF0238 |
AslA |
Invasion |
VFC0083 |
Homology to aslA of E. coli K12; based on its protein sequence, AslA is predicted to be a member of the arylsulfatase family of enzymes that contains highly conserved sulfatase motifs, but E. coli AslA failed to exhibit in vitro arylsulfatase activity |
(aslA) putative arylsulfatase [AslA (VF0238) - Invasion (VFC0083)] [Escherichia coli O18:K1:H7 str. RS218] |
Escherichia coli (NMEC) |
| AURV01000065.1_24 |
67.01 |
8.53E-144 |
wbtL |
VF0542 |
LPS |
Immune modulation |
VFC0258 |
The structure of Francisella spp. lipid A is unique in that it is modified by various carbohydrates that greatly reduce TLR4 activation and allow for immune evasion |
(wbtL) glucose-1-phosphate thymidylyltransferase [LPS (VF0542) - Immune modulation (VFC0258)] [Francisella tularensis subsp. tularensis SCHU S4] |
Francisella tularensis |
| AURV01000065.1_25 |
66.071 |
1.86E-171 |
rffG |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(rffG) dTDP-glucose 46-dehydratase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000067.1_16 |
63.964 |
5.49E-101 |
rpe |
VF0543 |
Capsule |
Immune modulation |
VFC0258 |
Group 4 capsule; high molecular weight (HMW) O-antigen capsule |
(rpe) ribulose-phosphate 3-epimerase [Capsule (VF0543) - Immune modulation (VFC0258)] [Francisella tularensis subsp. tularensis SCHU S4] |
Francisella tularensis |
| AURV01000073.1_62 |
64.931 |
0.0 |
acrB |
VF0568 |
AcrAB |
Antimicrobial activity/Competitive advantage |
VFC0325 |
|
(acrB) acriflavine resistance protein B [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000075.1_38 |
87.179 |
8.7E-18 |
rhs/PAAR |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(rhs/PAAR) Type VI secretion system protein, PAAR family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000077.1_1 |
71.651 |
0.0 |
fimD |
VF0102 |
Type 1 fimbriae |
Adherence |
VFC0001 |
Chaperone-usher assembly pathway |
(fimD) usher protein FimD [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000077.1_2 |
70.186 |
1.13E-170 |
fimH |
VF0102 |
Type 1 fimbriae |
Adherence |
VFC0001 |
Chaperone-usher assembly pathway |
(fimH) type I fimbriae minor fimbrial subunit FimH, adhesin [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000077.1_4 |
71.905 |
1.85E-112 |
fimZ |
VF0102 |
Type 1 fimbriae |
Adherence |
VFC0001 |
Chaperone-usher assembly pathway |
(fimZ) DNA-binding response regulator [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000077.1_11 |
98.906 |
0.0 |
ibeB |
VF0237 |
Ibes |
Invasion |
VFC0083 |
IbeA is unique to E. coli K1. The ibeB and ibeC are found to have K12 homologues p77211 and yijP respectively. |
(ibeB) Cu(+)/Ag(+) efflux RND transporter outer membrane channel CusC [Ibes (VF0237) - Invasion (VFC0083)] [Escherichia coli O45:K1:H7 str. S88] |
Escherichia coli (NMEC) |
| AURV01000079.1_1 |
100.0 |
2.5E-91 |
iucD |
VF0123 |
Aerobactin |
Nutritional/Metabolic factor |
VFC0272 |
A hydroxamate siderophore expressed in many strains of E. coli, Shigella flexneri and Klebsiella pneumoniae |
(iucD) aerobactin synthesis protein IucC, lysine 6-monooxygenase [Aerobactin (VF0123) - Nutritional/Metabolic factor (VFC0272)] [Shigella flexneri 2a str. 301] |
Shigella flexneri |
| AURV01000079.1_2 |
99.863 |
0.0 |
iutA |
VF0123 |
Aerobactin |
Nutritional/Metabolic factor |
VFC0272 |
A hydroxamate siderophore expressed in many strains of E. coli, Shigella flexneri and Klebsiella pneumoniae |
(iutA) aerobactin receptor IutA [Aerobactin (VF0123) - Nutritional/Metabolic factor (VFC0272)] [Shigella flexneri 2a str. 301] |
Shigella flexneri |
| AURV01000079.1_3 |
99.382 |
0.0 |
sat |
VF0231 |
Sat |
Effector delivery system |
VFC0086 |
Belongs to SPATE (serine protease autotransporters to Enterobacteriaceae) proteins (eight known SPATE proteins: Sat of UPEC, Pet of EAEC, EspC of EPEC, Pic of EAEC and Shigella, SigA of Shigella, SepA of Shigella, Tsh of avian E. coli, and EspP of EHEC); reside within PAI II of E. coli CFT073 |
(sat) Aecreted auto transpoter toxin [Sat (VF0231) - Effector delivery system (VFC0086)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000080.1_4 |
73.77 |
5.47E-23 |
clbK |
VF0573 |
Colibactin |
Exotoxin |
VFC0235 |
Colibactins are hybrid polyketide-nonribosomal peptides produced by Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, and Citrobacter koseri harboring the pks genomic island. |
(clbK) colibactin hybrid non-ribosomal peptide synthetase/type I polyketide synthase ClbK [Colibactin (VF0573) - Exotoxin (VFC0235)] [Klebsiella pneumoniae subsp. pneumoniae 1084] |
Klebsiella pneumoniae |
| AURV01000084.1_15 |
65.969 |
5.37E-91 |
algU |
VF0091 |
Alginate |
Biofilm |
VFC0271 |
Alginate production is frequently referred to as mucoidy because colonies producing alginate have a wet glistening (mucoid) appearance, which is very different from that of colonies not producing alginate; most of the alginate biosynthetic genes are clustered in the algD operon; Alginate production is highly regulated. Regulatory genes are located in two areas far removed from the biosynthetic genes, with one exception algC |
(algU) alginate biosynthesis protein AlgZ/FimS [Alginate (VF0091) - Biofilm (VFC0271)] [Pseudomonas aeruginosa PAO1] |
Pseudomonas aeruginosa |
| AURV01000095.1_18 |
60.287 |
6.81E-86 |
aatC |
VF0215 |
Dispersin |
Others |
VFC0346 |
Encoded by a gene called aap lying immediately upstream of that encoding the AggR transcriptional activator, and that app is under AggR control; Dispersin's position on the bacterial surface (where it is accessible to immune cells) and its presence in the vast majority of EAEC strains make it a potential candidate for vaccine development; exported by a putative ABC transporter complex encoded by a gene cluster designated aatPABCD |
(aatC) ATP-binding protein AatC [Dispersin (VF0215) - Others (VFC0346)] [Escherichia coli O44:H18 042] |
Escherichia coli (EAEC) |
| AURV01000099.1_7 |
61.111 |
2.43E-134 |
fimD |
VF0566 |
Type I fimbriae |
Adherence |
VFC0001 |
Type I fimbriae are expressed in 90% of both clinical and environmental K. pneumoniae isolates as well as almost all members of the Enterobacteriaceae.; Type I fimbriae are filamentous, membrane-bound, adhesive structures composed primarily of FimA subunits, with the FimH subunit on the tip. |
(fimD) outer membrane usher protein [Type I fimbriae (VF0566) - Adherence (VFC0001)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000112.1_1 |
81.356 |
8.18E-29 |
tufA |
VF0460 |
EF-Tu |
Adherence |
VFC0001 |
|
(tufA) elongation factor Tu [EF-Tu (VF0460) - Adherence (VFC0001)] [Francisella tularensis subsp. tularensis SCHU S4] |
Francisella tularensis |
| AURV01000113.1_17 |
72.414 |
0.0 |
KP1_RS17340 |
VF0560 |
Capsule |
Immune modulation |
VFC0258 |
The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. |
(KP1_RS17340) polysaccharide export protein [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000116.1_19 |
79.921 |
3.26E-152 |
espY1 |
VF1110 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espY1) Type III secretion system effector EspY1 [TTSS secreted effectors (VF1110) - Effector delivery system (VFC0086)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000116.1_53 |
89.006 |
0.0 |
espX1 |
VF1111 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espX1) Type III secretion system effector EspX1 [TTSS secreted effectors (VF1111) - Effector delivery system (VFC0086)] [Escherichia coli O55:H7 str. CB9615] |
Escherichia coli (EPEC) |
| AURV01000118.1_1 |
73.81 |
1.8E-103 |
vgrG/tssI |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(vgrG/tssI) type VI secretion system effector VgrG [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000118.1_2 |
73.275 |
0.0 |
rhs/PAAR |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(rhs/PAAR) Type VI secretion system protein, PAAR family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000121.1_29 |
80.115 |
0.0 |
tufA |
VF0460 |
EF-Tu |
Adherence |
VFC0001 |
|
(tufA) elongation factor Tu [EF-Tu (VF0460) - Adherence (VFC0001)] [Francisella tularensis subsp. tularensis SCHU S4] |
Francisella tularensis |
| AURV01000122.1_7 |
90.046 |
0.0 |
gspD |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspD) general secretion pathway protein D [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000122.1_8 |
97.384 |
0.0 |
gspE |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspE) general secretion pathway protein E [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000122.1_9 |
92.982 |
0.0 |
gspF |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspF) general secretion pathway protein F [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000122.1_10 |
98.013 |
1.62E-108 |
gspG |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspG) general secretion pathway protein G [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000122.1_11 |
84.492 |
2.16E-115 |
gspH |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspH) general secretion pathway protein H [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000122.1_12 |
93.496 |
2.67E-74 |
gspI |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspI) general secretion pathway protein I [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000122.1_13 |
84.08 |
1.68E-124 |
gspJ |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspJ) general secretion pathway protein J [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000122.1_14 |
67.385 |
1.07E-131 |
gspK |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspK) general secretion pathway protein K [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000122.1_15 |
92.092 |
0.0 |
gspL |
VF0333 |
T2SS |
Effector delivery system |
VFC0086 |
T2SS encoded by genes of the general secretion pathway (gsp) is widely distributed in Gram-negative bacteria. The known E.coli T2SS, responsible for chitinase secretion, encoded by the yhe genes at 74.5 min of the MG1655 chromosome is absent in all four sequenced Shigella genomes; A novel set of gsp genes are located on the S. dysenteriae Sd197 and S. boydii Sb227 chromosomes. The Sb227 T2SS is likely to be inactive due to a frameshift in gspC and a nonsense mutation in gspD. Those genes show significant similarity to those from ETEC and Vibrio cholerae responsible for secreting the E.coli heat labile toxin (Ltx) and cholera toxin (Ctx), respectively. While Shiga toxin has an overall similar structure to Ctx and Ltx. |
(gspL) general secretion pathway protein L [T2SS (VF0333) - Effector delivery system (VFC0086)] [Shigella dysenteriae Sd197] |
Shigella dysenteriae |
| AURV01000127.1_3 |
64.474 |
3.01E-33 |
prgI |
VF0116 |
TTSS (SPI-1 encode) |
Effector delivery system |
VFC0086 |
|
(prgI) type III secretion system needle filament protein PrgI [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000130.1_6 |
86.194 |
1.18E-176 |
allR |
VF0572 |
Allantion utilization |
Nutritional/Metabolic factor |
VFC0272 |
An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. |
(allR) DNA-binding transcriptional repressor AllR [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000130.1_7 |
74.375 |
1.46E-91 |
allA |
VF0572 |
Allantion utilization |
Nutritional/Metabolic factor |
VFC0272 |
An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. |
(allA) ureidoglycolate hydrolase [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000130.1_8 |
73.443 |
6.82E-173 |
allS |
VF0572 |
Allantion utilization |
Nutritional/Metabolic factor |
VFC0272 |
An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. |
(allS) DNA-binding transcriptional activator AllS [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000132.1_20 |
89.175 |
0.0 |
ugd |
VF0560 |
Capsule |
Immune modulation |
VFC0258 |
The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. |
(ugd) UDP-glucose 6-dehydrogenase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000132.1_21 |
93.376 |
0.0 |
gndA |
VF0560 |
Capsule |
Immune modulation |
VFC0258 |
The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. |
(gndA) NADP-dependent phosphogluconate dehydrogenase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000132.1_32 |
83.099 |
2.25E-38 |
galF |
VF0560 |
Capsule |
Immune modulation |
VFC0258 |
The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. |
(galF) GalU regulator GalF [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000135.1_1 |
93.401 |
1.39E-121 |
espX5 |
VF1111 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espX5) Type III secretion system effector EspX5 [TTSS secreted effectors (VF1111) - Effector delivery system (VFC0086)] [Escherichia coli O55:H7 str. CB9615] |
Escherichia coli (EPEC) |
| AURV01000137.1_8 |
98.387 |
0.0 |
entA |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(entA) 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase EntA [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_9 |
99.298 |
0.0 |
entB |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(entB) isochorismatase [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_10 |
99.067 |
0.0 |
entE |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(entE) 2,3-dihydroxybenzoate-AMP ligase component of enterobactin synthase multienzyme complex [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_11 |
99.488 |
0.0 |
entC |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(entC) isochorismate synthase 1 [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_12 |
100.0 |
0.0 |
fepB |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(fepB) ferrienterobactin ABC transporter periplasmic binding protein [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_13 |
99.279 |
0.0 |
entS |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(entS) enterobactin exporter, iron-regulated [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_14 |
99.401 |
0.0 |
fepD |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(fepD) ferrienterobactin ABC transporter permease [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_15 |
97.576 |
0.0 |
fepG |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(fepG) iron-enterobactin ABC transporter permease [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_16 |
99.259 |
0.0 |
fepC |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(fepC) ferrienterobactin ABC transporter ATPase [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_17 |
94.96 |
0.0 |
fepE |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(fepE) LPS O-antigen length regulator [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_18 |
96.906 |
0.0 |
entF |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(entF) enterobactin synthase multienzyme complex component, ATP-dependent [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_20 |
95.75 |
0.0 |
fes |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(fes) enterobactin/ferric enterobactin esterase [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_21 |
99.33 |
0.0 |
fepA |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(fepA) ferrienterobactin outer membrane transporter [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000137.1_22 |
95.631 |
9.1E-149 |
entD |
VF0228 |
Enterobactin |
Nutritional/Metabolic factor |
VFC0272 |
An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three |
(entD) phosphopantetheinyl transferase component of enterobactin synthase multienzyme complex [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] |
Escherichia coli (UPEC) |
| AURV01000146.1_14 |
100.0 |
1.24E-120 |
hcp1/tssD1 |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(hcp1/tssD1) type VI secretion system protein, Hcp family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000146.1_15 |
98.667 |
0.0 |
tssA |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(tssA) Type VI secretion system protein TssA [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000146.1_17 |
92.553 |
0.0 |
tssA |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(tssA) Type VI secretion system protein TssA [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000146.1_19 |
64.238 |
0.0 |
clpB |
VF0480 |
T6SS |
Effector delivery system |
VFC0086 |
|
(clpB) type VI secretion system ATPase ClpV1 [T6SS (VF0480) - Effector delivery system (VFC0086)] [Aeromonas hydrophila subsp. hydrophila ATCC 7966] |
Aeromonas hydrophila |
| AURV01000146.1_20 |
98.425 |
4.54E-88 |
tssL |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(tssL) Type VI secretion system protein TssL [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000149.1_19 |
73.958 |
2.16E-159 |
galU |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(galU) glucosephosphate uridylyltransferase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000152.1_4 |
90.991 |
1.08E-150 |
pmrA |
VF1355 |
PmrAB |
Regulation |
VFC0301 |
|
(pmrA) response regulator PmrA [PmrAB (VF1355) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000152.1_5 |
85.915 |
0.0 |
pmrB |
VF1355 |
PmrAB |
Regulation |
VFC0301 |
|
(pmrB) sensory kinase PmrB [PmrAB (VF1355) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000153.1_11 |
92.793 |
6.43E-73 |
espR1 |
VF1110 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espR1) Type III secretion system effector espR1 [TTSS secreted effectors (VF1110) - Effector delivery system (VFC0086)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000154.1_3 |
70.727 |
0.0 |
acrB |
VF0568 |
AcrAB |
Antimicrobial activity/Competitive advantage |
VFC0325 |
|
(acrB) acriflavine resistance protein B [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000156.1_1 |
82.54 |
6.65E-31 |
rhs/PAAR |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(rhs/PAAR) Type VI secretion system protein, PAAR family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000156.1_19 |
99.315 |
1.76E-107 |
fur |
VF0113 |
Fur |
Regulation |
VFC0301 |
|
(fur) ferric iron uptake transcriptional regulator [Fur (VF0113) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] |
Salmonella enterica (serovar typhimurium) |
| AURV01000158.1_1 |
100.0 |
8.25E-66 |
clbQ |
VF0573 |
Colibactin |
Exotoxin |
VFC0235 |
Colibactins are hybrid polyketide-nonribosomal peptides produced by Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, and Citrobacter koseri harboring the pks genomic island. |
(clbQ) colibactin biosynthesis thioesterase ClbQ [Colibactin (VF0573) - Exotoxin (VFC0235)] [Klebsiella pneumoniae subsp. pneumoniae 1084] |
Klebsiella pneumoniae |
| AURV01000158.1_2 |
98.824 |
2.43E-125 |
clbS |
VF0573 |
Colibactin |
Exotoxin |
VFC0235 |
Colibactins are hybrid polyketide-nonribosomal peptides produced by Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, and Citrobacter koseri harboring the pks genomic island. |
(clbS) colibactin self-protection protein ClbS [Colibactin (VF0573) - Exotoxin (VFC0235)] [Klebsiella pneumoniae subsp. pneumoniae 1084] |
Klebsiella pneumoniae |
| AURV01000161.1_1 |
96.703 |
0.0 |
espL4 |
VF1110 |
TTSS secreted effectors |
Effector delivery system |
VFC0086 |
|
(espL4) Type III secretion system effector EspL4 [TTSS secreted effectors (VF1110) - Effector delivery system (VFC0086)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000161.1_3 |
62.295 |
0.0 |
icl |
VF0253 |
Isocitrate lyase |
Others |
VFC0346 |
|
(icl) Isocitrate lyase Icl (isocitrase) (isocitratase) [Isocitrate lyase (VF0253) - Others (VFC0346)] [Mycobacterium tuberculosis H37Rv] |
Mycobacterium tuberculosis |
| AURV01000162.1_1 |
100.0 |
2.59E-96 |
tssL |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(tssL) Type VI secretion system protein TssL [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000162.1_3 |
99.425 |
3.94E-129 |
tssJ |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(tssJ) Type VI secretion system protein TssJ [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000162.1_4 |
99.765 |
0.0 |
fha |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(fha) Type VI secretion system protein Fha [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000162.1_5 |
99.444 |
0.0 |
tssG |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(tssG) Type VI secretion system protein TssG [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000162.1_6 |
99.513 |
0.0 |
tssF |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(tssF) Type VI secretion system protein TssF [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000162.1_8 |
73.131 |
0.0 |
vipB |
VF0480 |
T6SS |
Effector delivery system |
VFC0086 |
|
(vipB) Type VI secretion system contractile sheath large subunit TssC/VipB [T6SS (VF0480) - Effector delivery system (VFC0086)] [Aeromonas hydrophila subsp. hydrophila ATCC 7966] |
Aeromonas hydrophila |
| AURV01000162.1_10 |
98.795 |
2.47E-118 |
tssB |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(tssB) Type VI secretion system protein TssB [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000162.1_11 |
99.419 |
6.02E-131 |
hcp2/tssD2 |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(hcp2/tssD2) Type VI secretion system protein, Hcp family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000162.1_12 |
98.453 |
0.0 |
vgrG/tssI |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(vgrG/tssI) type VI secretion system effector VgrG [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000164.1_7 |
77.079 |
0.0 |
acrB |
VF0568 |
AcrAB |
Antimicrobial activity/Competitive advantage |
VFC0325 |
|
(acrB) acriflavine resistance protein B [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000164.1_8 |
78.393 |
0.0 |
acrB |
VF0568 |
AcrAB |
Antimicrobial activity/Competitive advantage |
VFC0325 |
|
(acrB) acriflavine resistance protein B [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000164.1_9 |
73.356 |
2.44E-151 |
acrA |
VF0568 |
AcrAB |
Antimicrobial activity/Competitive advantage |
VFC0325 |
|
(acrA) acriflavine resistance protein A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000166.1_3 |
81.625 |
1.99E-178 |
kdsA |
VF0044 |
LOS |
Immune modulation |
VFC0258 |
Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. |
(kdsA) 2-dehydro-3-deoxyphosphooctonate aldolase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] |
Haemophilus influenzae |
| AURV01000168.1_1 |
97.222 |
4.09E-130 |
ykgK/ecpR |
VF0404 |
ECP |
Adherence |
VFC0001 |
|
(ykgK/ecpR) regulator protein EcpR [ECP (VF0404) - Adherence (VFC0001)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000168.1_2 |
99.487 |
9.53E-138 |
yagZ/ecpA |
VF0404 |
ECP |
Adherence |
VFC0001 |
|
(yagZ/ecpA) E. coli common pilus structural subunit EcpA [ECP (VF0404) - Adherence (VFC0001)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000168.1_3 |
98.649 |
5.27E-165 |
yagY/ecpB |
VF0404 |
ECP |
Adherence |
VFC0001 |
|
(yagY/ecpB) E. coli common pilus chaperone EcpB [ECP (VF0404) - Adherence (VFC0001)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000168.1_4 |
99.524 |
0.0 |
yagX/ecpC |
VF0404 |
ECP |
Adherence |
VFC0001 |
|
(yagX/ecpC) E. coli common pilus usher EcpC [ECP (VF0404) - Adherence (VFC0001)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000168.1_5 |
99.086 |
0.0 |
yagW/ecpD |
VF0404 |
ECP |
Adherence |
VFC0001 |
|
(yagW/ecpD) polymerized tip adhesin of ECP fibers [ECP (VF0404) - Adherence (VFC0001)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000168.1_6 |
97.458 |
5.63E-175 |
yagV/ecpE |
VF0404 |
ECP |
Adherence |
VFC0001 |
|
(yagV/ecpE) E. coli common pilus chaperone EcpE [ECP (VF0404) - Adherence (VFC0001)] [Escherichia coli O157:H7 str. EDL933] |
Escherichia coli (EHEC) |
| AURV01000199.1_1 |
72.139 |
2.74E-93 |
rhs/PAAR |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(rhs/PAAR) Type VI secretion system protein, PAAR family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000199.1_2 |
65.562 |
0.0 |
rhs/PAAR |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(rhs/PAAR) Type VI secretion system protein, PAAR family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |
| AURV01000220.1_13 |
84.477 |
1.74E-179 |
allD |
VF0572 |
Allantion utilization |
Nutritional/Metabolic factor |
VFC0272 |
An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. |
(allD) ureidoglycolate dehydrogenase [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000234.1_1 |
84.887 |
0.0 |
acrA |
VF0568 |
AcrAB |
Antimicrobial activity/Competitive advantage |
VFC0325 |
|
(acrA) acriflavine resistance protein A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000234.1_2 |
91.516 |
0.0 |
acrB |
VF0568 |
AcrAB |
Antimicrobial activity/Competitive advantage |
VFC0325 |
|
(acrB) acriflavine resistance protein B [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] |
Klebsiella pneumoniae |
| AURV01000251.1_1 |
87.179 |
8.7E-18 |
rhs/PAAR |
VF0579 |
T6SS |
Effector delivery system |
VFC0086 |
|
(rhs/PAAR) Type VI secretion system protein, PAAR family [T6SS (VF0579) - Effector delivery system (VFC0086)] [Shigella sonnei Ss046] |
Shigella sonnei |